Armored macrophage-targeted CAR-T cells reset and reprogram the tumor microenvironment and control metastatic cancer growth

Jaime Mateus-Tique(Icahn School of Medicine at Mount Sinai), Brian D. Brown(Icahn School of Medicine at Mount Sinai), Alfonso R. Sánchez-Paulete(Icahn School of Medicine at Mount Sinai), Alessia Baccarini(Icahn School of Medicine at Mount Sinai), Alexander Tepper(Broad Institute), Gvantsa Pantsulaia(Icahn School of Medicine at Mount Sinai), Marco Colonna(Washington University in St. Louis), Gürkan Mollaoglu(New York University), Ashwitha Lakshmi(Icahn School of Medicine at Mount Sinai), Chiara Falcomatà(Icahn School of Medicine at Mount Sinai), Luisanna Pia(Icahn School of Medicine at Mount Sinai), Hunter Potak(Icahn School of Medicine at Mount Sinai), Divya Chhamalwan(Icahn School of Medicine at Mount Sinai), Bhavya Singh(Icahn School of Medicine at Mount Sinai), Miriam Merad(Icahn School of Medicine at Mount Sinai), Trung Nguyen(Icahn School of Medicine at Mount Sinai), Jessica Le Berichel(Icahn School of Medicine at Mount Sinai), Matthew Lin(Icahn School of Medicine at Mount Sinai), Angelo Amabile(Icahn School of Medicine at Mount Sinai), Rhea Iyer(Icahn School of Medicine at Mount Sinai), Joshua Brody(Icahn School of Medicine at Mount Sinai)
Cancer Cell
January 22, 2026
Cited by 5


Related Papers